Use of a tetrasubstituted pyrazolo(4,3-d)pyrimidine compound for treating diabetic nephropathy

• 收藏
• 分享

专利权人:

Pfizer Inc.

发明人:

Clerin, Valerie,Gale, Jeremy,Tamimi, Nihad

申请号：

AU2013336293

公开号：

AU2013336293B2

申请日:

2013.10.09

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention relates to methods of delaying progression to end stage renal disease (ESRD) in patients comprising administration of 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide. The present invention also includes administration of pharmaceutical compositions for delaying progression to ESRD. 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2-yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/